Nice article in Financial Times yesterday. It covers water recycling and other efforts underway in pharma, with a quick discussion of overall manufacturing issues. "The middle" of drug manufacturing is under control, the article points out, but the two ends (raw materials and packaging) need to improve.
AMS
